Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of COVID-19 and Risk Factors Associated With Seroconversion in La Rinconada, the Highest City of the World - 5,100 m

NCT04604249 is registered in ClinicalTrials.gov with Centre d'Expertise sur l'Altitude EXALT as lead sponsor.

NCT NCT04604249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04604249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of COVID-19 and Risk Factors Associated With Seroconversion in La Rinconada, the Highest City of the World - 5,100 m
Lead sponsor
Centre d'Expertise sur l'Altitude EXALT
Phase
Observational
Overall status
Unknown status
Start date
October 26, 2020
Completion date
December 31, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, high altitude